[Cytoplasmic androgen and estrogen receptor content in the tissues of human prostatic cancer].
D000230:Adenocarcinoma / Q000032:analysis* / Q000473:pathology / Q000628:therapy; D000368:Aged; D000375:Aging; D003131:Combined Modality Therapy; D003593:Cytoplasm / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011467:Prostate / Q000032:analysis; D011471:Prostatic Neoplasms / Q000032:analysis* / Q000473:pathology / Q000628:therapy; D011944:Receptors, Androgen / Q000032:analysis*; D011960:Receptors, Estrogen / Q000032:analysis*; D011987:Receptors, Steroid / Q000032:analysis*
D011944:Receptors, Androgen; D011960:Receptors, Estrogen; D011987:Receptors, Steroid
Soderzhanie tsitoplazmaticheskikh retseptorov androgenov i éstrogenov v tkaniakh raka predstatel'noĭ zhelezy cheloveka.